TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
<p>Background. Chronic myelogenous leukemia (CML) is a malignant clonal disorder of hematopoietic stem cell. In majority of patients we find reciprocal chromosomal translocation t (9.22) which result in fusion oncoprotein with tyrosine kinase activity. The normal ABL protein is involved in the...
| Prif Awduron: | , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
Slovenian Medical Association
2004-12-01
|
| Cyfres: | Zdravniški Vestnik |
| Pynciau: | |
| Mynediad Ar-lein: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2419 |